Skip to content
healthcare.dev

Griseofulvin

NDC 42794-012, Griseofulvin, tablet, from Sigmapharm Laboratories, LLC.

Product NDC
42794-012
Status
Listed
Labeler
Sigmapharm Laboratories, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202482
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42794-012 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GRISEOFULVIN500 mg/1

Pharmacologic classes

Decreased Mitosis [PE]; Microtubule Inhibition [PE]; Tubulin Inhibiting Agent [EPC]

Package NDCNDC-11Package
42794-012-084279400120830 TABLET in 1 BOTTLE (42794-012-08)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5bafb97f-621b-4b96-a787-68e0bb5c8637
  • NADAC price for package 42794001208

    GET /v1/drugs/nadac/42794001208

Use it

Look up 42794-012 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42794-012 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42794-012. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.